Cure Alzheimer’s Fund

Rejected Alzheimer’s drug shows new potential

Wednesday, August 1, 2012

An international team of scientists led by researchers at Mount Sinai School of Medicine have discovered that a drug that had previously yielded conflicting results in clinical trials for Alzheimer’s disease effectively stopped the progression of memory deterioration and brain pathology in mouse models of early stage Alzheimer’s disease. The findings, published July 31, 2012, in Molecular Psychiatry, demonstrate renewed potential for this compound and could lead to clinical trials in patients with early stages of the disease.

[Read More]